Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

November 6, 2020

Study Completion Date

November 6, 2020

Conditions
COVID-19
Interventions
DRUG

Hydroxychloroquine

Hydroxychloroquine: 400 mg PO every 12 hours for one day. Subsequently 200 mg every 12 hours per 4 more days.

DRUG

Ivermectin

Ivermectin 12 mg PO every 24 hours for one day (in case of weight less than 80 kg) or 18 mg PO every 24 hours for one day (in case of weight over 80 kg) Subsequently this group will take two tablets of placebo 12 hrs after ivermectin ingestion and then one tablet of placebo each 12 hrs per 4 more days.

DRUG

Placebo

Two tablets of placebo PO every 12 hours for one day. Subsequently one tablet of placebo every 12 hours per 4 more days.

Trial Locations (1)

20259

Jose Manuel Arreola Guerra, Aguascalientes

All Listed Sponsors
lead

Centenario Hospital Miguel Hidalgo

OTHER

NCT04391127 - Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection | Biotech Hunter | Biotech Hunter